Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Martha Gulati's new role at Cedars-Sinai | PCSK9 inhibition & severe COVID-19 | New data on mitral valve repair
Friday, January 20, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologist Martha Gulati named chair of women’s cardiovascular medicine and research at Cedars-Sinai

Gulati, an award-winning cardiologist and author, first joined Cedars-Sinai in 2022. She is also the president of the American Society for Preventive Cardiology.

READ MORE >
Cardiologist Martha Gulati, MD, who specializes in both preventive cardiology and cardiovascular disease in women, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research at Cedars-Sinai in Los Angeles.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist Martha Gulati named chair of women’s cardiovascular medicine and research at Cedars-Sinai

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist Martha Gulati, MD, who specializes in both preventive cardiology and cardiovascular disease in women, has been named the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research at Cedars-Sinai in Los Angeles.
Gulati, an award-winning cardiologist and author, first joined Cedars-Sinai in 2022. She is also the president of the American Society for Preventive Cardiology.
READ MORE >

PCSK9 inhibition may reduce risk of death for patients with severe COVID-19

A JACC pilot study suggests possible benefits for patients with severe cases of COVID-19 infection. 

READ MORE >
covid-19 coronavirus
Share on Twitter Share on Facebook Share on Linkedin

PCSK9 inhibition may reduce risk of death for patients with severe COVID-19

Share on Twitter Share on Facebook Share on Linkedin
covid-19 coronavirus
A JACC pilot study suggests possible benefits for patients with severe cases of COVID-19 infection. 
READ MORE >

An updated look at surgically repairing the mitral valve due to mitral regurgitation

A team of cardiologists and cardiac surgeons collaborated on the new analysis, reviewing data from more than 50,000 patients and developing a new risk model for clinicians.  

READ MORE >
A mitral valve open heart surgical repair.
Share on Twitter Share on Facebook Share on Linkedin

An updated look at surgically repairing the mitral valve due to mitral regurgitation

Share on Twitter Share on Facebook Share on Linkedin
A mitral valve open heart surgical repair.
A team of cardiologists and cardiac surgeons collaborated on the new analysis, reviewing data from more than 50,000 patients and developing a new risk model for clinicians.  
READ MORE >

Featured Articles

Intermittent fasting not associated with long-term weight loss, according to new 6-year analysis

Reducing total calorie intake and minimizing large meals, on the other hand, were both linked to improved weight loss. The study followed participants for an average of 6.3 years. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Intermittent fasting not associated with long-term weight loss, according to new 6-year analysis

Share on Twitter Share on Facebook Share on Linkedin
Reducing total calorie intake and minimizing large meals, on the other hand, were both linked to improved weight loss. The study followed participants for an average of 6.3 years. 
READ MORE >

EHR intervention targets acute kidney injuries after PCI

Contrast-associated acute kidney injury is a significant problem in cardiology, especially among patients undergoing percutaneous coronary intervention. Can EHR-generated alerts make an impact?

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

EHR intervention targets acute kidney injuries after PCI

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
Contrast-associated acute kidney injury is a significant problem in cardiology, especially among patients undergoing percutaneous coronary intervention. Can EHR-generated alerts make an impact?
READ MORE >

VIDEO: Pemafibrate does not lower cardiovascular risks in the PROMINENT trial

Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital and Harvard Medical School, explained some key takeaways from the PROMINENT trial.

READ MORE >
Peter Libby, MD, a cardiovascular medicine specialist, Brigham and Women’s Hospital, and Mallinckrodt Professor of Medicine, Harvard Medical School, explains the take aways from the PROMINENT trial using pemafibrate to lower cardiovascular risks. The trial, presented at the American Heart Association (AHA) 2022 meeting, did not show reduction in the incidence of cardiovascular events among those who received pemafibrate than among those who received placebo. #AHA #AHA22
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Pemafibrate does not lower cardiovascular risks in the PROMINENT trial

Share on Twitter Share on Facebook Share on Linkedin
Peter Libby, MD, a cardiovascular medicine specialist, Brigham and Women’s Hospital, and Mallinckrodt Professor of Medicine, Harvard Medical School, explains the take aways from the PROMINENT trial using pemafibrate to lower cardiovascular risks. The trial, presented at the American Heart Association (AHA) 2022 meeting, did not show reduction in the incidence of cardiovascular events among those who received pemafibrate than among those who received placebo. #AHA #AHA22
Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital and Harvard Medical School, explained some key takeaways from the PROMINENT trial.
READ MORE >

In Case You Missed It

COVID-19’s impact on cardiovascular health mostly felt in the first 30 days

The new study, published in PLOS ONE, included registry data from nearly 4,500 patients. While COVID-19 patients faced a heightened risk of adverse cardiovascular outcomes early on, many of those risks faded after approximately one month. 

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

COVID-19’s impact on cardiovascular health mostly felt in the first 30 days

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
The new study, published in PLOS ONE, included registry data from nearly 4,500 patients. While COVID-19 patients faced a heightened risk of adverse cardiovascular outcomes early on, many of those risks faded after approximately one month. 
READ MORE >

Stroke patients with AFib face a higher mortality risk after thrombectomy

A comparative meta-analysis found similar procedural outcomes, but higher 90-day mortality—partially attributable to a higher rate of comorbidities.

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

Stroke patients with AFib face a higher mortality risk after thrombectomy

Share on Twitter Share on Facebook Share on Linkedin
stroke
A comparative meta-analysis found similar procedural outcomes, but higher 90-day mortality—partially attributable to a higher rate of comorbidities.
READ MORE >

In Other News

CEO turnover dropped to lowest level since 2017 in second half of 2022

The Great Resignation hit the healthcare industry by storm during the COVID-19 pandemic, but turnover among CEOs slowed to its lowest level in five years toward the end of 2022.

READ MORE >
Hiring
Share on Twitter Share on Facebook Share on Linkedin

CEO turnover dropped to lowest level since 2017 in second half of 2022

Share on Twitter Share on Facebook Share on Linkedin
Hiring
The Great Resignation hit the healthcare industry by storm during the COVID-19 pandemic, but turnover among CEOs slowed to its lowest level in five years toward the end of 2022.
READ MORE >

More Americans are putting off care than ever before

The percentage of Americans who are postponing medical care has reached a new high, according to a recent Gallup poll.

READ MORE >
patient.jpg
Share on Twitter Share on Facebook Share on Linkedin

More Americans are putting off care than ever before

Share on Twitter Share on Facebook Share on Linkedin
patient.jpg
The percentage of Americans who are postponing medical care has reached a new high, according to a recent Gallup poll.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme